Charleen Shelley
Family · Independence, MONPI 1669002515
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,324 of the $3,756 with a category attached, or 88.5%. It is spread thinly across 35 manufacturers, the largest accounting for just 11.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,943, 6.5 times the $300 reported in 2021. Among family clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 167 payments — averaging $22.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$430
- AstraZeneca$399
- AbbVie$315
- Johnson & Johnson$243
- Astellas Pharma US Inc$236
- GSK$196
- plus $2K from 29 others
What the payments were for
- Food & beverage$3,32488%
- Education$43212%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 24 | $430 |
| AstraZeneca | 17 | $399 |
| AbbVie | 12 | $315 |
| Johnson & Johnson | 12 | $243 |
| Astellas Pharma US Inc | 5 | $236 |
| GSK | 9 | $196 |
| AVEO Pharmaceuticals, Inc. | 5 | $182 |
| Eisai Inc. | 10 | $178 |
| Novartis | 9 | $169 |
| Gilead | 3 | $141 |
| Pfizer | 5 | $120 |
| Daiichi Sankyo Inc. | 5 | $110 |
| Blueprint Medicines Corporation | 1 | $107 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $103 |
| Incyte Corporation | 5 | $92 |
| Genentech USA, Inc. | 5 | $86 |
| Ipsen Biopharmaceuticals, Inc | 3 | $67 |
| Legend Biotech USA Inc. | 3 | $58 |
| Taiho Oncology, Inc. | 3 | $56 |
| Genmab U.S., Inc. | 3 | $53 |
| Lilly USA, LLC | 3 | $49 |
| Stemline Therapeutics Inc. | 3 | $48 |
| Sanofi | 3 | $45 |
| Novocure Inc. | 2 | $33 |
| Regeneron Healthcare Solutions, Inc. | 2 | $30 |
| Tersera Therapeutics LLC | 1 | $30 |
| Array Biopharma Inc | 1 | $27 |
| Geron Corporation | 1 | $25 |
| Mirati Therapeutics, Inc. | 1 | $24 |
| Puma Biotechnology, Inc. | 1 | $20 |
| Cycle Pharmaceuticals Inc | 1 | $20 |
| Exelixis Inc. | 1 | $20 |
| Bayer | 1 | $16 |
| Pharmacosmos Therapeutics Inc. | 1 | $14 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AYVAKIT$107
How this compares
$3,756 in reported general payments places this provider in the 90th percentile of 3,812 family providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prochlorperazine Maleate | 38 | $350 |
| Ondansetron OdtOndansetron | 15 | $312 |
| Hydroxyurea | 15 | $305 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 22 | $252 |
| Warfarin Sodium | 40 | $215 |
| Dexamethasone | 14 | $206 |
| Ondansetron Hcl | 23 | $171 |
| Potassium Chloride | 20 | $164 |
Paid to pharmacies, not to this prescriber.
Other family in Independence
- Shayla SandersKansas City$306K
- Tamera WolfLees Summit$215K
- Tiffany ArnoldFestus$177K
- Tiffany NelsonSedalia$164K
- Chelsey BeckerSaint Peters$104K
- Carey PattonDes Peres$94K
- Marcy MarkesColumbia$92K
- Laura HedigerSpringfield$71K
- Rebecca SeabaughSaint Louis$68K
- Jennifer GriggColumbia$46K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.